CR7245A - FORMULATION OF STABILIZED ORAL SUSPENSION - Google Patents
FORMULATION OF STABILIZED ORAL SUSPENSIONInfo
- Publication number
- CR7245A CR7245A CR7245A CR7245A CR7245A CR 7245 A CR7245 A CR 7245A CR 7245 A CR7245 A CR 7245A CR 7245 A CR7245 A CR 7245A CR 7245 A CR7245 A CR 7245A
- Authority
- CR
- Costa Rica
- Prior art keywords
- formulation
- oral suspension
- stabilized oral
- thixotropic
- agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 229940100692 oral suspension Drugs 0.000 title 1
- 230000009974 thixotropic effect Effects 0.000 abstract 2
- 239000008135 aqueous vehicle Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Se proveen composiciones farmaceuticas para administrar en forma oral que comprenden una droga de baja solubilidad en agua suspendida en un vehiculo acuoso que comprende un agente humectante, un agente espesante tixotropico, y un agente de suspension inorganico. Las composiciones son tixotropicas, sustancialmente desfloculadas y fisicamente son estables de manera sustancial.Pharmaceutical compositions for oral administration are provided comprising a low water solubility drug suspended in an aqueous vehicle comprising a wetting agent, a thixotropic thickening agent, and an inorganic suspending agent. The compositions are thixotropic, substantially deflocculated and physically stable in a substantial manner.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7245A CR7245A (en) | 2004-02-05 | 2004-02-05 | FORMULATION OF STABILIZED ORAL SUSPENSION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7245A CR7245A (en) | 2004-02-05 | 2004-02-05 | FORMULATION OF STABILIZED ORAL SUSPENSION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7245A true CR7245A (en) | 2004-04-29 |
Family
ID=44839158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7245A CR7245A (en) | 2004-02-05 | 2004-02-05 | FORMULATION OF STABILIZED ORAL SUSPENSION |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR7245A (en) |
-
2004
- 2004-02-05 CR CR7245A patent/CR7245A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP044974A (en) | FORMULATION OF STABILIZED ORAL SUSPENSION | |
| BRPI0407845A (en) | intranasal formulation of rotigotine | |
| BRPI0615292A8 (en) | compositions and methods for preparing poorly soluble water drugs with increased stability | |
| PA8509001A1 (en) | DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL | |
| TR200801336T1 (en) | Compositions and methods for the preparation of drugs with increased stability to poor water solubility. | |
| AR038947A1 (en) | ORAL SUSPENSION OF NICE FLAVOR AND METHOD | |
| CL2004000931A1 (en) | CONSUMABLE FILM ADAPTED TO ADHER AND DISSOLVE IN THE ORAL CAVITY THAT INCLUDES A MODIFIED ALMIDON AND A PHARMACEUTICALLY ACTIVE AGENT. | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| BR0112311A (en) | Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use | |
| AR044923A1 (en) | IMIDAZOQUINOLINAS REPLACED WITH SULFONAMIDE | |
| WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
| EP1712240A4 (en) | STABLE AQUEOUS DRUG PREPARATION CONTAINING ANTIBODY | |
| WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
| MX2009004439A (en) | Ibuprofen composition. | |
| CO6400182A2 (en) | DOUBLE RELEASE PHARMACEUTICAL SUSPENSION | |
| BRPI0418330A (en) | solid compositions of low solubility drugs and poloxamers | |
| WO2007056205A3 (en) | Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents | |
| CL2004000899A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING TELMISARTAN SODIUM SALT AND A DIURETIC AGENT AND PREPARATION PROCEDURE. | |
| CY1110664T1 (en) | INTENSIVE COMPOSITION | |
| ATE541562T1 (en) | IBUPROFEN SUSPENSION | |
| UY38055A (en) | OPHTHALMIC COMPOSITIONS OF BENZIMIDAZOLE COMPOUNDS FOR SINGLE DAILY USE | |
| ITVA20040031A1 (en) | HIGH DISSOLUTION SPEED HYDROXIALKYL GUAR DERIVATIVES | |
| AR033293A1 (en) | COMPOSITIONS AND METHODS TO INCREASE THE BIODISPONIBILITY OF PHARMACEUTICAL AGENTS | |
| EP1993567A4 (en) | Orally administrable gallium compositions and method of use | |
| CO5590911A2 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |